Sensitization of cervix cancer cells to Adriamycin by Pentoxifylline induces an increase in apoptosis and decrease senescence

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Bravo Cuellar, Alejandro ^a,b   Ortiz Lazareno, Pablo C ^a   Lerma Diaz, Jose M ^a   Dominguez Rodriguez, Jorge R ^a   Jave Suarez, Luis F ^a   Aguilar Lemarroy, Adriana ^a   del Toro Arreola, Susana ^b   de Celis Carrillo, Ruth ^a   Sahagun Flores, Jose E ^b,c   de Alba Garcia, Javier E G ^a   Hernandez Flores, Georgina ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c Hospital Regional Dr Valentin Gomez Farias   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DNA; DOXORUBICIN; I KAPPA B ALPHA; MESSENGER RNA; METHYLXANTHINE; PENTOXIFYLLINE; PROTEIN E6; PROTEIN E7; PROTEIN P53; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CELL AGING; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; MICROSCOPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER; BIOSYNTHESIS; CELL SEPARATION; CELL SURVIVAL; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

HUMAN PAPILLOMAVIRUS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL AGING; CELL LINE, TUMOR; CELL SEPARATION; CELL SURVIVAL; DNA FRAGMENTATION; DOXORUBICIN; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELLS; HUMANS; PENTOXIFYLLINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 77952299096     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-114     Document Type: Article

References (38)

1. Arreygue-Garcia NA, Daneri-Navarro A, del Toro-Arreola A, Cid-Arregui A, Gonzalez-Ramella O, Jave-Suarez LF, Aguilar-Lemarroy A, Troyo-Sanroman R, Bravo-Cuellar A, Delgado-Rizo V, Garcia-Iglesias T, Hernandez-Flores G, Del Toro-Arreola S. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer 2008, 8:16. 10.1186/1471-2407-8-16, 2270854, 18208618.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
3. Alvarez-Salas LM, DiPaolo JA. Molecular approaches to cervical cancer therapy. Curr Drug Discov Technol 2007, 4:208-219. 10.2174/157016307782109661, 17986003.
4. Dominguez-Rodriguez JR, Gomez-Contreras PC, Hernandez-Flores G, Lerma-Diaz JM, Carranco A, Cervantes-Munguia R, Orbach-Arbouys S, Bravo-Cuellar A. In vivo inhibition by antioxidants of adriamycin-induced apoptosis in murine peritoneal macrophages. Anticancer Res 2001, 21:1869-1872.
5. Herr I, Debatin KM. Cellular stress response and apoptosis in cancer therapy. Blood 2001, 98:2603-2614. 10.1182/blood.V98.9.2603, 11675328.
6. Shabbits JA, Hu Y, Mayer LD. Tumor chemosensitization strategies based on apoptosis manipulations. Mol Cancer Ther 2003, 2:805-813.
7. Dominguez-Rodriguez JR, Chaparro-Huerta V, Hernandez-Flores G, Gomez-Contreras PC, Lerma-Diaz JM, Ortiz-Lazareno PC, Cervantes-Munguia R, Orbach-Arbouys S, Scott-Algara D, Bravo-Cuellar A. In vivo adriamycin-induced apoptosis in peritoneal murine macrophages: partial participation of a caspase cascade. Anticancer Res 2004, 24:2689-2696.
8. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007, 35:495-516. 10.1080/01926230701320337, 2117903, 17562483.
9. Hayflick L. The Limited in Vitro Lifetime of Human Diploid Cell Strains. Exp Cell Res 1965, 37:614-636. 10.1016/0014-4827(65)90211-9, 14315085.
10. Roninson IB. Tumor cell senescence in cancer treatment. Cancer Res 2003, 63:2705-2715.
11. Petignat P, Roy M. Diagnosis and management of cervical cancer. Bmj 2007, 335:765-768. 10.1136/bmj.39337.615197.80, 17932207.
12. Elmore LW, Rehder CW, Di X, McChesney PA, Jackson-Cook CK, Gewirtz DA, Holt SE. Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem 2002, 277:35509-35515. 10.1074/jbc.M205477200, 12101184.
13. Vigneron A, Roninson IB, Gamelin E, Coqueret O. Src inhibits adriamycin-induced senescence and G2 checkpoint arrest by blocking the induction of p21waf1. Cancer Res 2005, 65:8927-8935. 10.1158/0008-5472.CAN-05-0461, 16204065.
14. Hornsby PJ. Senescence as an anticancer mechanism. J Clin Oncol 2007, 25:1852-1857. 10.1200/JCO.2006.10.3101, 17488983.
15. Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, Zhao D, Bachoo RM, Pieper RO, Habib AA. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Res 2009, 69:2809-2816. 10.1158/0008-5472.CAN-08-4079, 2859885, 19339267.
16. Nakanishi C, Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 2005, 5:297-309. 10.1038/nrc1588, 15803156.
17. Wang CY, Cusack JC, Liu R, Baldwin AS. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 1999, 5:412-417. 10.1038/10577, 10202930.
18. Cusack JC, Liu R, Baldwin AS. NF- kappa B and chemoresistance: potentiation of cancer drugs via inhibition of NF- kappa B. Drug Resist Updat 1999, 2:271-273. 10.1054/drup.1999.0094, 11504498.
19. Bentires-Alj M, Merville MP, Bours V. NF- kappa B and chemoresistance: could NF- kappa B be an antitumor target?. Drug Resist Updat 1999, 2:274-276. 10.1054/drup.1999.0093, 11504499.
20. Bravo-Cuellar A, Gomez-Contreras PC, Lerma-Diaz JM, Hernandez-Flores G, Dominguez-Rodriguez JR, Ortiz-Lazareno P, Cervantes-Munguia R, Orbach-Arbouys S. In vivo modification of adriamycin-induced apoptosis in L-5178Y lymphoma cell-bearing mice by (+)-alpha-tocopherol and superoxide dismutase. Cancer Lett 2005, 229:59-65. 10.1016/j.canlet.2005.01.013, 16157219.
21. Lerma-Diaz JM, Hernandez-Flores G, Dominguez-Rodriguez JR, Ortiz-Lazareno PC, Gomez-Contreras P, Cervantes-Munguia R, Scott-Algara D, Aguilar-Lemarroy A, Jave-Suarez LF, Bravo-Cuellar A. In vivo and in vitro sensitization of leukemic cells to adriamycin-induced apoptosis by pentoxifylline. Involvement of caspase cascades and IkappaBalpha phosphorylation. Immunol Lett 2006, 103:149-158. 10.1016/j.imlet.2005.10.019, 16388856.
22. Bohm L, Roos WP, Serafin AM. Inhibition of DNA repair by Pentoxifylline and related methylxanthine derivatives. Toxicology 2003, 193:153-160. 10.1016/S0300-483X(03)00294-4, 14599774.
23. Lee SJ, Cho YS, Cho MC, Shim JH, Lee KA, Ko KK, Choe YK, Park SN, Hoshino T, Kim S, Dinarello CA, Yoon DY. Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells. J Immunol 2001, 167:497-504.
24. Gomez-Contreras PC, Hernandez-Flores G, Ortiz-Lazareno PC, Del Toro-Arreola S, Delgado-Rizo V, Lerma-Diaz JM, Barba-Barajas M, Dominguez-Rodriguez JR, Bravo-Cuellar A. In vitro induction of apoptosis in U937 cells by perillyl alcohol with sensitization by pentoxifylline: increased BCL-2 and BAX protein expression. Chemotherapy 2006, 52:308-315. 10.1159/000096003, 17008791.
25. Meissner JD. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 1999, 80(7):1725-1733.
26. Rishi L, Gahlot S, Kathania M, Majumdar S. Pentoxifylline induces apoptosis in vitro in cutaneous T cell lymphoma (HuT-78) and enhances FasL mediated killing by upregulating Fas expression. Biochem Pharmacol 2009, 77:30-45. 10.1016/j.bcp.2008.09.018, 18851957.
27. Braig M, Schmitt CA. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res 2006, 66:2881-2884. 10.1158/0008-5472.CAN-05-4006, 16540631.
28. Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001, 98:12072-12077. 10.1073/pnas.211053698, 59769, 11593017.
29. Campisi J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 2001, 11:S27-S31.
30. Drobna Z, Stein U, Walther W, Barancik M, Breier A. Pentoxifylline influences drug transport activity of P-glycoprotein and decreases mdrl gene expression in multidrug resistant mouse leukemic L1210/VCR cells. Gen Physiol Biophys 2002, 21:103-109.
31. Serafin AM, Binder AB, Bohm L. Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation. Urol Res 2001, 29:221-227. 10.1007/s002400100186, 11482451.
32. Shiu RP, Newsham IF, Gewirtz DA. Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to Adriamycin. Biochem Pharmacol 2009, 77:1139-1150. 10.1016/j.bcp.2008.12.016, 19185564.
33. Horvath B, Vekasi J, Kesmarky G, Toth K. In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model. Clin Hemorheol Microcirc 2008, 40:165-166.
34. Li J, Lee B, Lee AS. Endoplasmic reticulum stress-induced apoptosis: multiple pathways and activation of p53-up-regulated modulator of apoptosis (PUMA) and NOXA by p53. J Biol Chem 2006, 281:7260-7270. 10.1074/jbc.M509868200, 16407291.
35. Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K, Nakayama KI, Ide T, Saya H, Hara E. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 2006, 8:1291-1297. 10.1038/ncb1491, 17028578.
36. Lehmann BD, Paine MS, Brooks AM, McCubrey JA, Renegar RH, Wang R, Terrian DM. Senescence-associated exosome release from human prostate cancer cells. Cancer Res 2008, 68:7864-7871. 10.1158/0008-5472.CAN-07-6538, 18829542.
37. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. Clonogenic assay of cells in vitro. Nat Protoc 2006, 1:2315-2319. 10.1038/nprot.2006.339, 17406473.
38. Aguilar-Lemarroy A, Gariglio P, Whitaker NJ, Eichhorst ST, zur Hausen H, Krammer PH, Rosl F. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene 2002, 21:165-175. 10.1038/sj.onc.1204979, 11803460.